The FDA has granted marketing authorization to CT-132 for the preventive treatment of episodic migraine in patients aged 18 years and older.

The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive treatment of episodic migraine.

SAN DIEGO — An adjunctive, first-in-class investigational prescription digital therapeutic significantly reduced monthly migraine days (MMDs) in patients with episodic migraine (EM) compared ...

In late February, Hyfe announced plans to launch a prescription digital therapeutic to treat chronic cough. This is part of a growing industry trend towards the use of digital therapeutics. Hyfe’s ...

Keep in mind, there’s a big difference between holistic wellness apps and actual digital therapeutics that connect you to a licensed mental health provider. Apps can only go so far. There may be ...

Collins Aerospace is the newest member of Airbus’s Digital Alliance for Aviation, an alliance with members including Airbus, Delta TechOps, GE Aerospace and Liebherr. The Digital Alliance focuses on ...

ATLANTA, April 8, 2025 /PRNewswire/ -- Collins Aerospace, an RTX (NYSE: RTX) business, will advance predictive health monitoring solutions for airlines as part of the Digital Alliance for Aviation ...

April 8, 2025 /PRNewswire/ -- The Secure Identity Alliance (SIA) and the Accountable Digital Identity Association (ADIA) are pleased to announce a strategic partnership to advance trusted digital ...

Lupin Digital Health marked the company’s foray into the fast-growing digital therapeutics space. Its Lyfe platform focuses on real-time monitoring of patients and offers interventions for ...